Lu PJ - Search Results

1

Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells.

Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, Tang NY, Lu PJ, Weng JR, Chung JG. Lu KW, et al. Among authors: lu pj. In Vivo. 2010 May-Jun;24(3):287-91. In Vivo. 2010. PMID: 20555000

2

Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.

Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, Lu PJ, Weng JR, Chueh FS, Wood WG, Chung JG. Lu KW, et al. Among authors: lu pj. Hum Exp Toxicol. 2011 May;30(5):406-15. doi: 10.1177/0960327110372405. Epub 2010 May 28. Hum Exp Toxicol. 2011. PMID: 20511288

3

Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives.

Tseng CH, Chen YL, Lu PJ, Yang CN, Tzeng CC. Tseng CH, et al. Among authors: lu pj. Bioorg Med Chem. 2008 Mar 15;16(6):3153-62. doi: 10.1016/j.bmc.2007.12.028. Epub 2007 Dec 23. Bioorg Med Chem. 2008. PMID: 18180162

4

Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease.

Feng YH, Wu CL, Tsao CJ, Chang JG, Lu PJ, Yeh KT, Uen YH, Lee JC, Shiau AL. Feng YH, et al. Among authors: lu pj. Cancer Biol Ther. 2011 Jan 1;11(1):111-21. doi: 10.4161/cbt.11.1.13965. Epub 2011 Jan 1. Cancer Biol Ther. 2011. PMID: 21099344 Free article.

5

TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cells.

Liu YP, Chen HL, Tzeng CC, Lu PJ, Lo CW, Lee YC, Tseng CH, Chen YL, Yang CN. Liu YP, et al. Among authors: lu pj. Breast Cancer Res Treat. 2013 Apr;138(2):383-93. doi: 10.1007/s10549-013-2441-1. Epub 2013 Feb 22. Breast Cancer Res Treat. 2013. PMID: 23430225

6

Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.

Cheng HC, Liu YP, Shan YS, Huang CY, Lin FC, Lin LC, Lee L, Tsai CH, Hsiao M, Lu PJ. Cheng HC, et al. Among authors: lu pj. Carcinogenesis. 2013 Nov;34(11):2452-9. doi: 10.1093/carcin/bgt218. Epub 2013 Jun 17. Carcinogenesis. 2013. PMID: 23774402

7

Synthesis and antiproliferative evaluation of 4-anilino-n-methoxyfuro[2,3-b]quinoline derivatives (n=6, 7). Part 5.

Chen YL, Lin HC, Yang CN, Lu PJ, Tzeng CC. Chen YL, et al. Among authors: lu pj. Chem Biodivers. 2008 Feb;5(2):267-78. doi: 10.1002/cbdv.200890024. Chem Biodivers. 2008. PMID: 18293440

8

Synthesis of 2-styrylchromones as a novel class of antiproliferative agents targeting carcinoma cells.

Shaw AY, Chang CY, Liau HH, Lu PJ, Chen HL, Yang CN, Li HY. Shaw AY, et al. Among authors: lu pj. Eur J Med Chem. 2009 Jun;44(6):2552-62. doi: 10.1016/j.ejmech.2009.01.034. Epub 2009 Feb 6. Eur J Med Chem. 2009. PMID: 19246129

9

MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.

Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, Lin JT, Chen YL, Lu PJ. Lee KH, et al. Among authors: lu pj. Exp Cell Res. 2009 Sep 10;315(15):2529-38. doi: 10.1016/j.yexcr.2009.06.001. Epub 2009 Jun 6. Exp Cell Res. 2009. PMID: 19501585

10

MicroRNA-21-mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5-fluorouracil and metformin in colon cancer cells.

Feng YH, Wu CL, Shiau AL, Lee JC, Chang JG, Lu PJ, Tung CL, Feng LY, Huang WT, Tsao CJ. Feng YH, et al. Among authors: lu pj. Int J Mol Med. 2012 May;29(5):920-6. doi: 10.3892/ijmm.2012.910. Epub 2012 Feb 9. Int J Mol Med. 2012. PMID: 22322462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters